iHeart Japan Corporation
PrivateLast Round
Series D
Sep 1, 2025
Total Funding Raised
$19.22M
Company Overview
iHeart Japan Corporation is a biotechnology company that develops and sells allogeneic regenerative medical products and research tools derived from iPS cells for the treatment of heart failure.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iHeart Japan Corporation Comps
Public and private peers based on sector, stage, and business model.
iHeart Japan Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Sep 1, 2025 | ||||
| Series C | Jul 6, 2021 | ||||
| Series B | May 16, 2016 |
iHeart Japan Corporation Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Mitsui Sumitomo Insurance | Series D |
| Miraidoa | Series C |
| Senshu Ikeda Capital | Series B |
| SBI Investment Co., Ltd. | Series B |
| Real Tech Fund | Series B |
iHeart Japan Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about iHeart Japan Corporation's valuation, stock price, and market status.
